Arkadios Wealth Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
68,760
+6,734
| +11% | +$259K | 0.08% | 270 |
|
|
2025
Q1 | $2.4M | Buy |
62,026
+7,468
| +14% | +$289K | 0.09% | 245 |
|
|
2024
Q4 | $1.85M | Sell |
54,558
-105
| -0.2% | -$3.55K | 0.1% | 198 |
|
|
2024
Q3 | $2.23M | Sell |
54,663
-406
| -0.7% | -$16.6K | 0.13% | 168 |
|
|
2024
Q2 | $2.12M | Sell |
55,069
-2,938
| -5% | -$113K | 0.14% | 156 |
|
|
2024
Q1 | $2.49M | Sell |
58,007
-147
| -0.3% | -$6.3K | 0.19% | 121 |
|
|
2023
Q4 | $2.16M | Sell |
58,154
-301
| -0.5% | -$11.2K | 0.18% | 122 |
|
|
2023
Q3 | $2.12M | Sell |
58,455
-712
| -1% | -$25.8K | 0.2% | 119 |
|
|
2023
Q2 | $2.11M | Sell |
59,167
-567
| -0.9% | -$20.2K | 0.25% | 100 |
|
|
2023
Q1 | $2.13M | Sell |
59,734
-3,902
| -6% | -$139K | 0.25% | 106 |
|
|
2022
Q4 | $1.55M | Buy |
63,636
+308
| +0.5% | +$7.52K | 0.21% | 122 |
|
|
2022
Q3 | $1.29M | Buy |
63,328
+4,984
| +9% | +$102K | 0.2% | 136 |
|
|
2022
Q2 | $3.18M | Sell |
58,344
-8
| -0% | -$435 | 0.47% | 51 |
|
|
2022
Q1 | $3.18M | Buy |
58,352
+13,546
| +30% | +$738K | 0.42% | 57 |
|
|
2021
Q4 | $2.47M | Sell |
44,806
-711
| -2% | -$39.2K | 0.33% | 76 |
|
|
2021
Q3 | $2.17M | Buy |
45,517
+1,623
| +4% | +$77.5K | 0.31% | 84 |
|
|
2021
Q2 | $2.18M | Buy |
43,894
+41,290
| +1,586% | +$2.05M | 0.27% | 101 |
|
|
2021
Q1 | $116K | Buy |
2,604
+214
| +9% | +$9.53K | 0.02% | 505 |
|
|
2020
Q4 | $109K | Buy |
+2,390
| New | +$109K | 0.02% | 422 |
|
|
2020
Q2 | – | Sell |
-418
| Closed | -$19.8K | – | 1027 |
|
|
2020
Q1 | $19.8K | Hold |
418
| – | – | 0.01% | 489 |
|
|
2019
Q4 | $22.9K | Buy |
+418
| New | +$22.9K | 0.01% | 434 |
|